MeiraGTx Holdings (MGTX) Retained Earnings (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Retained Earnings of $2.4 million for Q4 2025, up 100.29% on a QoQ basis from -$831.3 million in Q3 2025, and up 100.34% year-over-year from $1.2 million in Q4 2024.
MeiraGTx Holdings (MGTX) Retained Earnings (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Retained Earnings history runs 9 years deep, the most recent figure standing at $2.4 million for Q4 2025.
- Quarterly Retained Earnings rose 100.34% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (up 100.34% YoY) and the FY2025 annual result came in at $2.4 million, up 100.34% from the prior year.
- Retained Earnings was $2.4 million for Q4 2025 at MeiraGTx Holdings, up from -$831.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $791.3 million in Q2 2025 and bottomed at -$831.3 million in Q3 2025.
- A 5-year average of -$126.5 million and a median of -$187.3 million in 2021 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2021 — Retained Earnings jumped 23628.3% — and 2023, when it plunged 204.41%.
- MeiraGTx Holdings' Retained Earnings stood at -$2.7 million in 2021, then jumped by 21885.59% to $581.9 million in 2022, then tumbled by 195.25% to -$554.2 million in 2023, then declined by 26.67% to -$702.0 million in 2024, then soared by 100.34% to $2.4 million in 2025.
- Business Quant data shows MGTX's Retained Earnings at $2.4 million in Q4 2025, -$831.3 million in Q3 2025, and $791.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | -831.30 Mn |
| Jun 30, 2025 | 791.28 Mn |
| Mar 31, 2025 | -742.00 Mn |
| Dec 31, 2024 | -702.02 Mn |
| Sep 30, 2024 | -662.60 Mn |
| Jun 30, 2024 | -623.30 Mn |
| Mar 31, 2024 | -574.67 Mn |
| Dec 31, 2023 | -554.23 Mn |
| Sep 30, 2023 | -574.45 Mn |
| Jun 30, 2023 | 652.52 Mn |
| Mar 31, 2023 | -500.57 Mn |
| Dec 31, 2022 | 581.89 Mn |
| Sep 30, 2022 | 550.17 Mn |
| Jun 30, 2022 | 6.62 Mn |
| Mar 31, 2022 | -371.60 Mn |
| Dec 31, 2021 | -2.67 Mn |
| Sep 30, 2021 | -2.91 Mn |
| Jun 30, 2021 | 516.03 Mn |
| Mar 31, 2021 | 510.61 Mn |